Jazz Pharmaceuticals at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

Jazz Pharmaceuticals brings 2 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 1642. The biopharma company's posters report survival and treatment discontinuation after trastuzumab deruxtecan in HER2-positive metastatic disease.

OrganizationSABCS 2026 Attendance
Jazz Pharmaceuticals
Dublin, Ireland
Pharma
Global biopharma company with medicines for serious diseases, including zanidatamab, a HER2-targeted bispecific antibody studied in breast cancer.
Booth
Exhibiting at Booth 1642
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Thu Dec 10
12:30–2pm

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Jazz Pharmaceuticals

Tell us what you sell and we’ll find the people at Jazz Pharmaceuticals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction